CoChat

PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis

Open access

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Mutant p53-carrying tumors are often more resistant to chemotherapeutical drugs. We demonstrate here that the mutant p53-reactivating compound PRIMA-1(MET) acts synergistically with several chemotherapeutic drugs to inhibit tumor cell growth. Combined treatment with cisplatin and PRIMA-1(MET) resulted in a synergistic induction of tumor cell apoptosis and inhibition of human tumor xenograft growth in vivo in SCID mice. The induction of mutant p53 levels by chemotherapeutic drugs is likely to increase the sensitivity of tumor cells to PRIMA-1(MET). Thus, the combination of PRIMA-1(MET) with currently used chemotherapeutic drugs may represent a novel and more efficient therapeutic strategy for treatment of mutant p53-carrying tumors.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1208419

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 19 references

Cited by

See all 255

Metadata

Authors
Bykov, V. J. N., Zache, N., Stridh, H., Westman, J., Bergman, J., Selivanova, G., & Wiman, K. G.
Affiliations
Karolinska Institutet (SE)
Corresponding author
Wiman, Klas G
Venue
Oncogene
Published
2005-02-28
Volume
24
Issue
21
Pages
3484-3491
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2006422601
Cited by
252
References
19
Citations by year
2026: 4 · 2025: 11 · 2024: 12 · 2023: 14 · 2022: 16 · 2021: 21 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 7 · 2016: 16 · 2015: 11 · 2014: 7 · 2013: 9 · 2012: 11
FWCI
6.37
Type
journal article
Language
en
Open access
Licence
Locations
  • Oncogene (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Cancerfonden
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
Keywords
mutant p53 reactivation, cisplatin, drug synergy, apoptosis, chemoresistance, combination chemotherapy, xenograft tumor growth, SCID mice
MeSH terms
Adenocarcinoma, Animals, Aza Compounds, Bone Neoplasms, Carcinoma, Non-Small-Cell Lung, Cisplatin, Drug Interactions, Humans, Lung Neoplasms, Mutation, Quinuclidines, Osteosarcoma, Transplantation, Heterologous, Tumor Cells, Cultured, Genes, p53, Mice, SCID, Apoptosis, Drug Resistance, Neoplasm, Bridged Bicyclo Compounds, Heterocyclic, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis. https://app.cochat.ai/papers/10.1038/sj.onc.1208419
The paper
Bykov, V. J. N., Zache, N., Stridh, H., Westman, J., Bergman, J., Selivanova, G., & Wiman, K. G. (2005). PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis. Oncogene. https://doi.org/10.1038/sj.onc.1208419

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.